Schedule 13G ownership disclosure
Health Catalyst Inc
Common Stock, par value $0.001 per share · CUSIP: 42225T107
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Whetstone Capital Advisors, LLC
Shares: 3,750,377 · Class: 5.3%
- David Atterbury
Shares: 3,750,377 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-013333
- Form type
- SCHEDULE 13G/A
- Filer
- Health Catalyst, Inc.
- CIK
- CIK 1636422
- Filed
- Jan 14, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership